Lab Rats series: A Bengaluru startup’s bid to drug the undruggable
Summary
Backed by an ₹86 crore government grant and ₹70 crore Series A funding, Peptris Technologies is leveraging generative AI to build a preclinical pipeline targeting rare diseases and previously undruggable proteins.
Description from Livemint.
Who is covering this
-
Lab Rats series: A Bengaluru startup’s bid to drug the undruggable
Backed by an ₹86 crore government grant and ₹70 crore Series A funding, Peptris Technologies is leveraging generative AI to build a preclinical pipeline targeting rare diseases and previously undruggable proteins.
